{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T16:40:04Z","timestamp":1746981604179,"version":"3.40.5"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,11]]},"DOI":"10.7759\/cureus.83900","type":"journal-article","created":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T16:08:31Z","timestamp":1746979711000},"source":"Crossref","is-referenced-by-count":0,"title":["Bone Marrow Findings in Patients With Renal Disease: Experience of a Single Tertiary Care Center in Bihar"],"prefix":"10.7759","author":[{"given":"Rawi","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaushal","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijayanand","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/nep.14420","article-title":"Chronic kidney disease prevalence in India: a systematic review and meta-analysis from community-based representative evidence between 2011 to 2023","volume":"30","author":"Talukdar R","year":"2025","unstructured":"Talukdar R, Ajayan R, Gupta S, et al.. Chronic kidney disease prevalence in India: a systematic review and meta-analysis from community-based representative evidence between 2011 to 2023. Nephrology (Carlton). 2025, 30:e14420. 10.1111\/nep.14420","journal-title":"Nephrology (Carlton)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.18912","article-title":"Bone marrow findings in renal patients: a single renal specialist center experience","volume":"13","author":"Nasir K","year":"2021","unstructured":"Nasir K, Qureshi R, Qureshi H, Dhrolia M, Ahmad A. Bone marrow findings in renal patients: a single renal specialist center experience. Cureus. 2021, 13:e18912. 10.7759\/cureus.18912","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/267257","article-title":"Peripheral vascular dysfunction in chronic kidney disease","volume":"2011","author":"Martens CR","year":"2011","unstructured":"Martens CR, Edwards DG. Peripheral vascular dysfunction in chronic kidney disease. Cardiol Res Pract. 2011, 2011:267257. 10.4061\/2011\/267257","journal-title":"Cardiol Res Pract"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2013.198","article-title":"Evaluating bone quality in patients with chronic kidney disease","volume":"9","author":"Malluche HH","year":"2013","unstructured":"Malluche HH, Porter DS, Pienkowski D. Evaluating bone quality in patients with chronic kidney disease. Nat Rev Nephrol. 2013, 9:671-80. 10.1038\/nrneph.2013.198","journal-title":"Nat Rev Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7860\/NJLM\/2023\/65750.2779","article-title":"Morphological spectrum of bone marrow changes in patients of chronic kidney disease: a cross-sectional study","volume":"12","author":"Singh MK","year":"2023","unstructured":"Singh MK, Sengar NS, Khan SA, Kumar A. Morphological spectrum of bone marrow changes in patients of chronic kidney disease: a cross-sectional study. Natl J Lab Med. 2023, 12:PO49-53. 10.7860\/NJLM\/2023\/65750.2779","journal-title":"Natl J Lab Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.64719","article-title":"Epidemiology and clinical characteristics of chronic kidney disease in Bihar: a cross-sectional study from a single center","volume":"16","author":"Singh PP","year":"2024","unstructured":"Singh PP, Patel PS, Krishna A, Kuntal S, Kumar S, Kumar O. Epidemiology and clinical characteristics of chronic kidney disease in Bihar: a cross-sectional study from a single center. Cureus. 2024, 16:e64719. 10.7759\/cureus.64719","journal-title":"Cureus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3390\/toxins12070439","article-title":"Immune dysfunction in uremia 2020","volume":"12","author":"Cohen G","year":"2020","unstructured":"Cohen G. Immune dysfunction in uremia 2020. Toxins (Basel). 2020, 12:439. 10.3390\/toxins12070439","journal-title":"Toxins (Basel)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2007.08.001","article-title":"Epidemiology of the plasma-cell disorders","volume":"20","author":"Kyle RA","year":"2007","unstructured":"Kyle RA, Rajkumar SV. Epidemiology of the plasma-cell disorders. Best Pract Res Clin Haematol. 2007, 20:637-64. 10.1016\/j.beha.2007.08.001","journal-title":"Best Pract Res Clin Haematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.8791","article-title":"Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group","volume":"28","author":"Dimopoulos MA","year":"2010","unstructured":"Dimopoulos MA, Terpos E, Chanan-Khan A, et al.. Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group. J Clin Oncol. 2010, 28:4976-84. 10.1200\/JCO.2010.30.8791","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2180373","article-title":"Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome","volume":"2018","author":"Mihai S","year":"2018","unstructured":"Mihai S, Codrici E, Popescu ID, et al.. Inflammation-related mechanisms in chronic kidney disease prediction, progression, and outcome. J Immunol Res. 2018, 2018:2180373. 10.1155\/2018\/2180373","journal-title":"J Immunol Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5527\/wjn.v4.i2.295","article-title":"African origins and chronic kidney disease susceptibility in the human immunodeficiency virus era","volume":"4","author":"Kasembeli AN","year":"2015","unstructured":"Kasembeli AN, Duarte R, Ramsay M, Naicker S. African origins and chronic kidney disease susceptibility in the human immunodeficiency virus era. World J Nephrol. 2015, 4:295-306. 10.5527\/wjn.v4.i2.295","journal-title":"World J Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/cells9092039","article-title":"Uremic toxins affect erythropoiesis during the course of chronic kidney disease: a review","volume":"9","author":"Hamza E","year":"2020","unstructured":"Hamza E, Metzinger L, Metzinger-Le Meuth V. Uremic toxins affect erythropoiesis during the course of chronic kidney disease: a review. Cells. 2020, 9:2039. 10.3390\/cells9092039","journal-title":"Cells"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110583","article-title":"Indoxyl sulfate impairs erythropoiesis at BFU-E stage in chronic kidney disease","volume":"104","author":"Hamza E","year":"2023","unstructured":"Hamza E, Vallejo-Mudarra M, Ouled-Haddou H, et al.. Indoxyl sulfate impairs erythropoiesis at BFU-E stage in chronic kidney disease. Cell Signal. 2023, 104:110583. 10.1016\/j.cellsig.2022.110583","journal-title":"Cell Signal"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2012.02.009","article-title":"Does my patient with a serum monoclonal spike have multiple myeloma?","volume":"26","author":"Bianchi G","year":"2012","unstructured":"Bianchi G, Ghobrial IM. Does my patient with a serum monoclonal spike have multiple myeloma?. Hematol Oncol Clin North Am. 2012, 26:383-93, ix. 10.1016\/j.hoc.2012.02.009","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/1744-9987.14086","article-title":"Evaluation of bone marrow findings in hemodialysis patients with erythropoietin-resistant anemia","volume":"28","author":"Yilmaz M","year":"2024","unstructured":"Yilmaz M, Karaku\u015f V, Kaya E, \u0130lhanl\u0131 N, Huddam B. Evaluation of bone marrow findings in hemodialysis patients with erythropoietin-resistant anemia. Ther Apher Dial. 2024, 28:218-24. 10.1111\/1744-9987.14086","journal-title":"Ther Apher Dial"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/363419-bone-marrow-findings-in-patients-with-renal-disease-experience-of-a-single-tertiary-care-center-in-bihar","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T16:08:31Z","timestamp":1746979711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/363419-bone-marrow-findings-in-patients-with-renal-disease-experience-of-a-single-tertiary-care-center-in-bihar"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,11]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.83900","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,11]]}}}